<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36880667</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-1547</ISSN><JournalIssue CitedMedium="Internet"><Volume>324</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>American journal of physiology. Gastrointestinal and liver physiology</Title><ISOAbbreviation>Am J Physiol Gastrointest Liver Physiol</ISOAbbreviation></Journal><ArticleTitle>Role of the microbiota-gut-brain axis in postacute COVID syndrome.</ArticleTitle><Pagination><StartPage>G322</StartPage><EndPage>G328</EndPage><MedlinePgn>G322-G328</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1152/ajpgi.00293.2022</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has resulted in the infection of hundreds of millions of individuals over the past 3 years, coupled with millions of deaths. Along with these more acute impacts of infection, a large subset of patients has developed symptoms that collectively comprise "postacute sequelae of COVID-19" (PASC, also known as long COVID), which can persist for months and maybe even years. In this review, we outline the current knowledge on the role of impaired microbiota-gut-brain (MGB) axis signaling in the development of PASC and the potential mechanisms involved, which may lead to a better understanding of disease progression and treatment options in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gareau</LastName><ForeName>M&#xe9;lanie G</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0001-6008-6975</Identifier><AffiliationInfo><Affiliation>School of Veterinary Medicine, University of California, Davis, Davis, California, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrett</LastName><ForeName>Kim E</ForeName><Initials>KE</Initials><Identifier Source="ORCID">0000-0002-6704-998X</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of California, Davis, Sacramento, California, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AT009365</GrantID><Acronym>AT</Acronym><Agency>NCCIH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Physiol Gastrointest Liver Physiol</MedlineTA><NlmUniqueID>100901227</NlmUniqueID><ISSNLinking>0193-1857</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000087502" MajorTopicYN="Y">Brain-Gut Axis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cognitive function</Keyword><Keyword MajorTopicYN="N">microbiota-gut-brain</Keyword></KeywordList><CoiStatement>Melanie Gareau is an editor of <i>American Journal of Physiology-Gastrointestinal and Liver Physiology</i> and was not involved and did not have access to information regarding the peer-review process or final disposition of this article. An alternate editor oversaw the peer-review and decision-making process for this article. None of the other authors has any conflicts of interest, financial or otherwise, to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>7</Day><Hour>8</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36880667</ArticleId><ArticleId IdType="pmc">PMC10042594</ArticleId><ArticleId IdType="doi">10.1152/ajpgi.00293.2022</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Han JH, Womack KN, Tenforde MW, Files DC, Gibbs KW, Shapiro NI, Prekker ME, Erickson HL, Steingrub JS, Qadir N, Khan A, Hough CL, Johnson NJ, Ely EW, Rice TW, Casey JD, Lindsell CJ, Gong MN, Srinivasan V, Lewis NM, Patel MM, Self WH; Influenza and Other Viruses in the Acutely Ill (IVY) Network. Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress. Influenza Other Respir Viruses 16: 680&#x2013;689, 2022. doi:10.1111/irv.12980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12980</ArticleId><ArticleId IdType="pmc">PMC9111447</ArticleId><ArticleId IdType="pubmed">35347854</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deeks SG. Early clues regarding the pathogenesis of long-COVID. Trends Immunol 43: 268&#x2013;270, 2022. doi:10.1016/j.it.2022.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.02.008</ArticleId><ArticleId IdType="pmc">PMC8901423</ArticleId><ArticleId IdType="pubmed">35272932</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunvoll SH, Nygaard AB, Fagerland MW, Holland P, Ellingjord-Dale M, Dahl JA, S&#xf8;raas A. Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection. Int J Infect Dis 126: 10&#x2013;13, 2023. doi:10.1016/j.ijid.2022.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.11.009</ArticleId><ArticleId IdType="pmc">PMC9651990</ArticleId><ArticleId IdType="pubmed">36375693</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisis SN, Durieux JC, Mouchati C, Perez JA, McComsey GA. The protective effect of coronavirus disease 2019 (COVID-19) vaccination on postacute sequelae of COVID-19: a multicenter study from a large national health research network. Open Forum Infect Dis 9: ofac228, 2022. doi:10.1093/ofid/ofac228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac228</ArticleId><ArticleId IdType="pmc">PMC9129153</ArticleId><ArticleId IdType="pubmed">35818362</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21: 133&#x2013;146, 2023. doi:10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel HK, Kovacic R, Chandrasekar VT, Patel SC, Singh M, Le Cam E, Burton JH, Ray A, Shah JN. Correlation of gastrointestinal symptoms at initial presentation with clinical outcomes in hospitalized COVID-19 patients: results from a large health system in the southern USA. Dig Dis Sci 67: 5034&#x2013;5043, 2022. doi:10.1007/s10620-022-07384-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-022-07384-0</ArticleId><ArticleId IdType="pmc">PMC8818361</ArticleId><ArticleId IdType="pubmed">35128607</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A, Tariq R, Jena A, Vesely EK, Singh S, Khanna S, Sharma V. Gastrointestinal manifestations of long COVID: a systematic review and meta-analysis. Therap Adv Gastroenterol 15: 175628482211184, 2022. doi:10.1177/17562848221118403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17562848221118403</ArticleId><ArticleId IdType="pmc">PMC9393939</ArticleId><ArticleId IdType="pubmed">36004306</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, Suen J, Robba C, Fraser J, Cho SM. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci 434: 120162, 2022. doi:10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Chasco EE, Dukes K, Jones D, Comellas AP, Hoffman RM, Garg A. Brain fog and fatigue following COVID-19 infection: an exploratory study of patient experiences of long COVID. Int J Environ Res Public Health 19: 15499, 2022. doi:10.3390/ijerph192315499.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192315499</ArticleId><ArticleId IdType="pmc">PMC9737348</ArticleId><ArticleId IdType="pubmed">36497573</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in people with covid-19: cohort study. BMJ 376: e068993, 2022. doi:10.1136/bmj-2021-068993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068993</ArticleId><ArticleId IdType="pmc">PMC8847881</ArticleId><ArticleId IdType="pubmed">35172971</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC, Ng SSS, Zhang F, Li AYL, Lu W, Hui DS, Chan PK, Chan FKL, Ng SC. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut 71: 544&#x2013;552, 2022. doi:10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryan JF, O'Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, Guzzetta KE, Jaggar M, Long-Smith CM, Lyte JM, Martin JA, Molinero-Perez A, Moloney G, Morelli E, Morillas E, O'Connor R, Cruz-Pereira JS, Peterson VL, Rea K, Ritz NL, Sherwin E, Spichak S, Teichman EM, van de Wouw M, Ventura-Silva AP, Wallace-Fitzsimons SE, Hyland N, Clarke G, Dinan TG. The microbiota-gut-brain axis. Physiol Rev 99: 1877&#x2013;2013, 2019. doi:10.1152/physrev.00018.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00018.2018</ArticleId><ArticleId IdType="pubmed">31460832</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostick JW, Schonhoff AM, Mazmanian SK. Gut microbiome-mediated regulation of neuroinflammation. Curr Opin Immunol 76: 102177, 2022. doi:10.1016/j.coi.2022.102177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2022.102177</ArticleId><ArticleId IdType="pmc">PMC9167715</ArticleId><ArticleId IdType="pubmed">35462279</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennessey C, Keogh CE, Barboza M, Brust-Mascher I, Knotts TA, Sladek JA, Pusceddu MM, Stokes P, Rabasa G, Honeycutt M, Walsh O, Nichols R, Reardon C, Gareau MG. Neonatal enteropathogenic Escherichia coli infection disrupts microbiota-gut-brain axis signaling. Infect Immun 89: e0005921, 2021. doi:10.1128/IAI.00059-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.00059-21</ArticleId><ArticleId IdType="pmc">PMC8370682</ArticleId><ArticleId IdType="pubmed">33820817</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvo E, Stokes P, Keogh CE, Brust-Mascher I, Hennessey C, Knotts TA, Sladek JA, Rude KM, Swedek M, Rabasa G, Gareau MG. A murine model of pediatric inflammatory bowel disease causes microbiota-gut-brain axis deficits in adulthood. Am J Physiol Gastrointest Liver Physiol 319: G361&#x2013;G374, 2020. doi:10.1152/ajpgi.00177.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00177.2020</ArticleId><ArticleId IdType="pmc">PMC7509259</ArticleId><ArticleId IdType="pubmed">32726162</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz Heijtz R, Wang S, Anuar F, Qian Y, Bj&#xf6;rkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 108: 3047&#x2013;3052, 2011. doi:10.1073/pnas.1010529108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1010529108</ArticleId><ArticleId IdType="pmc">PMC3041077</ArticleId><ArticleId IdType="pubmed">21282636</ArticleId></ArticleIdList></Reference><Reference><Citation>Gareau MG, Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ, MacQueen G, Sherman PM. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 60: 307&#x2013;317, 2011. doi:10.1136/gut.2009.202515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2009.202515</ArticleId><ArticleId IdType="pubmed">20966022</ArticleId></ArticleIdList></Reference><Reference><Citation>Keogh CE, Kim DHJ, Pusceddu MM, Knotts TA, Rabasa G, Sladek JA, Hsieh MT, Honeycutt M, Brust-Mascher I, Barboza M, Gareau MG. Myelin as a regulator of development of the microbiota-gut-brain axis. Brain Behav Immun 91: 437&#x2013;450, 2021. doi:10.1016/j.bbi.2020.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.11.001</ArticleId><ArticleId IdType="pmc">PMC7749851</ArticleId><ArticleId IdType="pubmed">33157256</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogbonnaya ES, Clarke G, Shanahan F, Dinan TG, Cryan JF, O'Leary OF. Adult hippocampal neurogenesis is regulated by the microbiome. Biol Psychiatry 78: e7&#x2013;9, 2015. doi:10.1016/j.biopsych.2014.12.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2014.12.023</ArticleId><ArticleId IdType="pubmed">25700599</ArticleId></ArticleIdList></Reference><Reference><Citation>Erny D, Hrab&#x11b; de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T, Schwierzeck V, Uterm&#xf6;hlen O, Chun E, Garrett WS, McCoy KD, Diefenbach A, Staeheli P, Stecher B, Amit I, Prinz M. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18: 965&#x2013;977, 2015. doi:10.1038/nn.4030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4030</ArticleId><ArticleId IdType="pmc">PMC5528863</ArticleId><ArticleId IdType="pubmed">26030851</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler ES, Bailey AL, Kafai NM, Nair S, McCune BT, Yu J, Fox JM, Chen RE, Earnest JT, Keeler SP, Ritter JH, Kang LI, Dort S, Robichaud A, Head R, Holtzman MJ, Diamond MS. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat Immunol 21: 1327&#x2013;1335, 2020. [Erratum in Nat Immunol 2020] doi:10.1038/s41590-020-0778-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0778-2</ArticleId><ArticleId IdType="pmc">PMC7578095</ArticleId><ArticleId IdType="pubmed">32839612</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler ES, Chen RE, Alam F, Yildiz S, Case JB, Uccellini MB, Holtzman MJ, Garcia-Sastre A, Schotsaert M, Diamond MS. SARS-CoV-2 causes lung infection without severe disease in human ACE2 knock-in mice. J Virol 96: e0151121, 2022. doi:10.1128/JVI.01511-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01511-21</ArticleId><ArticleId IdType="pmc">PMC8754206</ArticleId><ArticleId IdType="pubmed">34668780</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen EB, Orvold SN, Swan CL, Yourkowski A, Thivierge BM, Francis ME, Ge A, Rioux M, Darbellay J, Howland JG, Kelvin AA. After the virus has cleared-Can preclinical models be employed for Long COVID research? PLoS Pathog 18: e1010741, 2022. doi:10.1371/journal.ppat.1010741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010741</ArticleId><ArticleId IdType="pmc">PMC9451097</ArticleId><ArticleId IdType="pubmed">36070309</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan K, Lin Y, Prewitt KM, Potter DA. Multidisciplinary approach to brain fog and related persisting symptoms post COVID-19. J Health Serv Psychol 48: 31&#x2013;38, 2022. doi:10.1007/s42843-022-00056-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42843-022-00056-7</ArticleId><ArticleId IdType="pmc">PMC8809226</ArticleId><ArticleId IdType="pubmed">35128461</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P, Benito Ballesteros A, Yeung SP, Liu R, Saha A, Curtis L, Kaser M, Haggard MP, Cheke LG. COVCOG 1: factors predicting physical, neurological and cognitive symptoms in long COVID in a community sample. A first publication from the COVID and cognition study. Front Aging Neurosci 14: 804922, 2022. doi:10.3389/fnagi.2022.804922.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.804922</ArticleId><ArticleId IdType="pmc">PMC8968323</ArticleId><ArticleId IdType="pubmed">35370617</ArticleId></ArticleIdList></Reference><Reference><Citation>Sylvester SV, Rusu R, Chan B, Bellows M, O&#x2019;Keefe C, Nicholson S. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. Curr Med Res Opin 38: 1391&#x2013;1399, 2022. doi:10.1080/03007995.2022.2081454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2081454</ArticleId><ArticleId IdType="pubmed">35726132</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensterle M, Herman R, Jane&#x17e; A, Mahmeed WA, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Galia M, Goh SY, Kalra S, Kempler P, Lessan N, Lotufo P, Papanas V, Rizvi AA, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M. The relationship between COVID-19 and hypothalamic-pituitary-adrenal axis: a large spectrum from glucocorticoid insufficiency to excess-The CAPISCO International Expert Panel. Int J Mol Sci 23: 7326, 2022. doi:10.3390/ijms23137326.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137326</ArticleId><ArticleId IdType="pmc">PMC9266848</ArticleId><ArticleId IdType="pubmed">35806331</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanriverdi F, Karaca Z, Unluhizarci K, Kelestimur F. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress 10: 13&#x2013;25, 2007. doi:10.1080/10253890601130823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10253890601130823</ArticleId><ArticleId IdType="pubmed">17454963</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, Song E, Lee MH, Wood J, , et al. . Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell 185: 2452&#x2013;2468.e16, 2022. doi:10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, Lucin KM, Czirr E, Park JS, Couillard-Despr&#xe9;s S, Aigner L, Li G, Peskind ER, Kaye JA, Quinn JF, Galasko DR, Xie XS, Rando TA, Wyss-Coray T. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477: 90&#x2013;94, 2011. doi:10.1038/nature10357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10357</ArticleId><ArticleId IdType="pmc">PMC3170097</ArticleId><ArticleId IdType="pubmed">21886162</ArticleId></ArticleIdList></Reference><Reference><Citation>Roswall J, Olsson LM, Kovatcheva-Datchary P, Nilsson S, Tremaroli V, Simon MC, Kiilerich P, Akrami R, Kr&#xe4;mer M, Uhl&#xe9;n M, Gummesson A, Kristiansen K, Dahlgren J, B&#xe4;ckhed F. Developmental trajectory of the healthy human gut microbiota during the first 5 years of life. Cell Host Microbe 29: 765&#x2013;776.e3, 2021. doi:10.1016/j.chom.2021.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.02.021</ArticleId><ArticleId IdType="pubmed">33794185</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson LM, Boulund F, Nilsson S, Khan MT, Gummesson A, Fagerberg L, Engstrand L, Perkins R, Uhl&#xe9;n M, Bergstr&#xf6;m G, Tremaroli V, B&#xe4;ckhed F. Dynamics of the normal gut microbiota: a longitudinal one-year population study in Sweden. Cell Host Microbe 30: 726&#x2013;739.e3, 2022. doi:10.1016/j.chom.2022.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2022.03.002</ArticleId><ArticleId IdType="pubmed">35349787</ArticleId></ArticleIdList></Reference><Reference><Citation>Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL, Clemente JC, Knight R, Heath AC, Leibel RL, Rosenbaum M, Gordon JI. The long-term stability of the human gut microbiota. Science 341: 1237439, 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3791589</ArticleId><ArticleId IdType="pubmed">23828941</ArticleId></ArticleIdList></Reference><Reference><Citation>Boolchandani M, Blake KS, Tilley DH, Cabada MM, Schwartz DJ, Patel S, Morales ML, Meza R, Soto G, Isidean SD, Porter CK, Simons MP, Dantas G. Impact of international travel and diarrhea on gut microbiome and resistome dynamics. Nat Commun 13: 7485, 2022. doi:10.1038/s41467-022-34862-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34862-w</ArticleId><ArticleId IdType="pmc">PMC9722912</ArticleId><ArticleId IdType="pubmed">36470885</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng X, Zhang Y, Li Y, Wu Q, Wu J, Park SK, Guo C, Lu J. Meta-analysis of 16S rRNA microbial data identified alterations of the gut microbiota in COVID-19 patients during the acute and recovery phases. BMC Microbiol 22: 274, 2022. doi:10.1186/s12866-022-02686-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-022-02686-9</ArticleId><ArticleId IdType="pmc">PMC9662111</ArticleId><ArticleId IdType="pubmed">36376804</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Su Q, Zhang F, Tun HM, Mak JWY, Lui GC, Ng SSS, Ching JYL, Li A, Lu W, Liu C, Cheung CP, Hui DSC, Chan PKS, Chan FKL, Ng SC. Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome. Nat Commun 13: 6806, 2022. doi:10.1038/s41467-022-34535-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34535-8</ArticleId><ArticleId IdType="pmc">PMC9648868</ArticleId><ArticleId IdType="pubmed">36357381</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, Zuo T, Lui GC, Zhang F, Liu Q, Li AY, Chung AC, Cheung CP, Tso EY, Fung KS, Chan V, Ling L, Joynt G, Hui DS, Chow KM, Ng SSS, Li TC, Ng RW, Yip TC, Wong GL, Chan FK, Wong CK, Chan PK, Ng SC. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 70: 698&#x2013;706, 2021. doi:10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran JP, Bradley E, Zeamer AL, Cincotta L, Salive MC, Dutta P, Mutaawe S, Anya O, Meza-Segura M, Moormann AM, Ward DV, McCormick BA, Bucci V. Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID. JCI Insight 6: e152346, 2021. doi:10.1172/jci.insight.152346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.152346</ArticleId><ArticleId IdType="pmc">PMC8564890</ArticleId><ArticleId IdType="pubmed">34403368</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurath MF, &#xdc;berla K, Ng SC. Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19. Gut 70: 1605&#x2013;1608, 2021. doi:10.1136/gutjnl-2021-324622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324622</ArticleId><ArticleId IdType="pubmed">33903146</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Liu Q, Zhang F, Yeoh YK, Wan Y, Zhan H, Lui GCY, Chen Z, Li AYL, Cheung CP, Chen N, Lv W, Ng RWY, Tso EYK, Fung KSC, Chan V, Ling L, Joynt G, Hui DSC, Chan FKL, Chan PKS, Ng SC. Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity. Microbiome 9: 91, 2021. doi:10.1186/s40168-021-01008-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-021-01008-x</ArticleId><ArticleId IdType="pmc">PMC8044506</ArticleId><ArticleId IdType="pubmed">33853691</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J, Wang C, Zhang Y, Lei G, Xu K, Zhao N, Lu J, Meng F, Yu L, Yan J, Bai C, Zhang S, Zhang N, Gong Y, Bi Y, Shi Y, Chen Z, Dai L, Wang J, Yang P. Integrated gut virome and bacteriome dynamics in COVID-19 patients. Gut Microbes 13: 1&#x2013;21, 2021. doi:10.1080/19490976.2021.1887722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.1887722</ArticleId><ArticleId IdType="pmc">PMC7946006</ArticleId><ArticleId IdType="pubmed">33678150</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhan H, Zhang F, Liu Q, Tso EYK, Lui GCY, Chen N, Li A, Lu W, Chan FKL, Chan PKS, Ng SC. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology 159: 1302&#x2013;1310.e5, 2020. doi:10.1053/j.gastro.2020.06.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.06.048</ArticleId><ArticleId IdType="pmc">PMC7318920</ArticleId><ArticleId IdType="pubmed">32598884</ArticleId></ArticleIdList></Reference><Reference><Citation>Naveen KV, Saravanakumar K, Sathiyaseelan A, MubarakAli D, Wang MH. Human fungal infection, immune response, and clinical challenge-a perspective during COVID-19 pandemic. Appl Biochem Biotechnol 194: 4244&#x2013;4257, 2022. doi:10.1007/s12010-022-03979-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12010-022-03979-5</ArticleId><ArticleId IdType="pmc">PMC9156836</ArticleId><ArticleId IdType="pubmed">35648275</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TH, Hsu MT, Lee MY, Chou CK. Gastrointestinal involvement in SARS-CoV-2 infection. Viruses 14: 1188, 2022. doi:10.3390/v14061188.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14061188</ArticleId><ArticleId IdType="pmc">PMC9228950</ArticleId><ArticleId IdType="pubmed">35746659</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, Ravelli RBG, Paul van Schayck J, Mykytyn AZ, Duimel HQ, van Donselaar E, Riesebosch S, Kuijpers HJH, Schipper D, van de Wetering WJ, de Graaf M, Koopmans M, Cuppen E, Peters PJ, Haagmans BL, Clevers H. SARS-CoV-2 productively infects human gut enterocytes. Science 369: 50&#x2013;54, 2020. doi:10.1126/science.abc1669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc1669</ArticleId><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M&#xfc;ller MA, Drosten C, P&#xf6;hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181: 271&#x2013;280.e8, 2020. doi:10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedberg DE, Chang L. Gastrointestinal symptoms in COVID-19: the long and the short of it. Curr Opin Gastroenterol 38: 555&#x2013;561, 2022. doi:10.1097/MOG.0000000000000876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOG.0000000000000876</ArticleId><ArticleId IdType="pubmed">36165028</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebert JT, Scribano F, Engevik KA, Perry JL, Hyser JM. Gastrointestinal organoids in the study of viral infections. Am J Physiol Gastrointest Liver Physiol 324: G51&#x2013;G59, 2023. doi:10.1152/ajpgi.00152.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00152.2022</ArticleId><ArticleId IdType="pmc">PMC9799139</ArticleId><ArticleId IdType="pubmed">36414538</ArticleId></ArticleIdList></Reference><Reference><Citation>Giobbe GG, Bonfante F, Jones BC, Gagliano O, Luni C, Zambaiti E, Perin S, Laterza C, Busslinger G, Stuart H, Pagliari M, Bortolami A, Mazzetto E, Manfredi A, Colantuono C, Di Filippo L, Pellegata AF, Panzarin V, Thapar N, Li VSW, Eaton S, Cacchiarelli D, Clevers H, Elvassore N, De Coppi P. SARS-CoV-2 infection and replication in human gastric organoids. Nat Commun 12: 6610, 2021. doi:10.1038/s41467-021-26762-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26762-2</ArticleId><ArticleId IdType="pmc">PMC8595698</ArticleId><ArticleId IdType="pubmed">34785679</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang KK, Kaczmarek ME, Dallari S, Chen YH, Tada T, Axelrad J, Landau NR, Stapleford KA, Cadwell K. Variable susceptibility of intestinal organoid-derived monolayers to SARS-CoV-2 infection. PLoS Biol 20: e3001592, 2022. doi:10.1371/journal.pbio.3001592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001592</ArticleId><ArticleId IdType="pmc">PMC9004766</ArticleId><ArticleId IdType="pubmed">35358182</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad R, Patton MJ, Floyd JL, Fortmann S, DuPont M, Harbour A, Wright J, Lamendella R, Stevens BR, Oudit GY, Grant MB. Plasma microbiome in COVID-19 subjects: an indicator of gut barrier defects and dysbiosis. Int J Mol Sci 23: 9141, 2022. doi:10.3390/ijms23169141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23169141</ArticleId><ArticleId IdType="pmc">PMC9409329</ArticleId><ArticleId IdType="pubmed">36012406</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Han J. Rethinking sepsis after a two-year battle with COVID-19. Cell Mol Immunol 19: 1317&#x2013;1318, 2022. doi:10.1038/s41423-022-00909-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-022-00909-7</ArticleId><ArticleId IdType="pmc">PMC9434097</ArticleId><ArticleId IdType="pubmed">36050479</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks EF, Vance SE, Dahlen A, Hedlin H, Park RM, Han A, Schmidtke DT, Verma R, Jacobson KB, Parsonnet J, Bonilla HF, Singh U, Pinsky BA, Andrews JR, Jagannathan P, Bhatt AS. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med (NY) 3: 371&#x2013;387 e9, 2022. doi:10.1016/j.medj.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi Jet al., Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185: 881&#x2013;895.e20, 2022. doi:10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Budden KF, Gellatly SL, Wood DL, Cooper MA, Morrison M, Hugenholtz P, Hansbro PM. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol 15: 55&#x2013;63, 2017. doi:10.1038/nrmicro.2016.142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2016.142</ArticleId><ArticleId IdType="pubmed">27694885</ArticleId></ArticleIdList></Reference><Reference><Citation>Durrani SR, Mukkada VA, Guilbert TW. Eosinophilic esophagitis: an important comorbid condition of asthma? Clin Rev Allergy Immunol 55: 56&#x2013;64, 2018. doi:10.1007/s12016-018-8670-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-018-8670-7</ArticleId><ArticleId IdType="pmc">PMC8048773</ArticleId><ArticleId IdType="pubmed">29455359</ArticleId></ArticleIdList></Reference><Reference><Citation>Laorden D, Dom&#xed;nguez-Ortega J, Carpio C, Barranco P, Villama&#xf1;&#xe1;n E, Romero D, Quirce S, &#xc1;lvarez-Sala R; ASMA@COVIDHULP group. Long COVID outcomes in an asthmatic cohort and its implications for asthma control. Respir Med 207: 107092, 2023. doi:10.1016/j.rmed.2022.107092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2022.107092</ArticleId><ArticleId IdType="pmc">PMC9755318</ArticleId><ArticleId IdType="pubmed">36535372</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard-Raichon L, Venzon M, Klein J, Axelrad JE, Zhang C, Sullivan AP, Hussey GA, Casanovas-Massana A, Noval MG, Valero-Jimenez AM, Gago J, Putzel G, Pironti A, Wilder E; Yale IMPACT Research Team; Thorpe LE, Littman DR, Dittmann M, Stapleford KA, Shopsin B, Torres VJ, Ko AI, Iwasaki A, Cadwell K, Schluter J. Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia. Nat Commun 13: 5926, 2022. doi:10.1038/s41467-022-33395-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33395-6</ArticleId><ArticleId IdType="pmc">PMC9626559</ArticleId><ArticleId IdType="pubmed">36319618</ArticleId></ArticleIdList></Reference><Reference><Citation>Stutz MR, Dylla NP, Pearson SD, Lecompte-Osorio P, Nayak R, Khalid M, Adler E, Boissiere J, Lin H, Leiter W, Little J, Rose A, Moran D, Mullowney MW, Wolfe KS, Lehmann C, Odenwald M, De La Cruz M, Giurcanu M, Pohlman AS, Hall JB, Chaubard J-L, Sundararajan A, Sidebottom A, Kress JP, Pamer EG, Patel BK. Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure. Nat Commun 13: 6615, 2022. doi:10.1038/s41467-022-34260-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34260-2</ArticleId><ArticleId IdType="pmc">PMC9633022</ArticleId><ArticleId IdType="pubmed">36329015</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarden N, Sinha S, Potts KG, Pernet E, Hiroki CH, Hassanabad MF, Nguyen AP, Lou Y, Farias R, Winston BW, Bromley A, Snarr BD, Zucoloto AZ, Andonegui G, Muruve DA, McDonald B, Sheppard DC, Mahoney DJ, Divangahi M, Rosin N, Biernaskie J, Yipp BG. A B1a-natural IgG-neutrophil axis is impaired in viral- and steroid-associated aspergillosis. Sci Transl Med 14: eabq6682, 2022. doi:10.1126/scitranslmed.abq6682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq6682</ArticleId><ArticleId IdType="pubmed">36475902</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen LD, Viscogliosi E, Delhaes L. The lung mycobiome: an emerging field of the human respiratory microbiome. Front Microbiol 6: 89, 2015. doi:10.3389/fmicb.2015.00089.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2015.00089</ArticleId><ArticleId IdType="pmc">PMC4327734</ArticleId><ArticleId IdType="pubmed">25762987</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>